Teva’s generic EpiPen approved in the U.S., with perfect timing
August 16, 2018 at 14:25 PM EDT
The U.S. has had monthslong shortages of Mylan’s EpiPen and other products, causing parents to worry as back-to-school season approaches.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.